MAPT and Alzheimer disease: Differentially expressed proteins included those known to be increased in AD, for example CSNK1A1 (CK1α), CSNK1D (CK1δ) and MAPT (Tau), which are associated with GVD and tau pathology respectively (Fig. 2d).